Jane Street Group, LLC Amicus Therapeutics, Inc. Put Options Transaction History

Jane Street Group, LLC

10 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2022 May 17, 2022	BUY	$7.89 - $12.48 $445,785 - $705,120	56,500 Added 73.76%	133,100 $1.26 Million
Q4 2021 Feb 15, 2022	SELL	$9.82 - $12.44 $326,024 - $413,008	-33,200 Reduced 30.24%	76,600 $885,000
Q3 2021 Nov 16, 2021	BUY	$8.74 - $11.84 $374,072 - $506,752	42,800 Added 63.88%	109,800 $1.05 Million
Q2 2021 Aug 16, 2021	SELL	$8.71 - $10.72 $472,082 - $581,024	-54,200 Reduced 44.72%	67,000 $646,000
Q1 2021 May 18, 2021	BUY	$9.2 - $23.86 $977,039 - $2.53 Million	106,200 Added 708.0%	121,200 $1.2 Million
Q4 2020 Feb 17, 2021	BUY	$13.47 - $24.89 $22,899 - $42,313	1,700 Added 12.78%	15,000 $346,000
Q3 2020 Nov 17, 2020	SELL	$12.89 - $15.89 $1.13 Million - $1.39 Million	-87,400 Reduced 86.79%	13,300 $188,000
Q1 2020 May 15, 2020	BUY	$6.63 - $11.16 $567,528 - $955,296	85,600 Added 566.89%	100,700 $930,000
Q3 2018 Nov 14, 2018	SELL	$11.6 - $16.54 $80,040 - $114,126	-6,900 Reduced 31.36%	15,100 $183,000
Q1 2018 May 15, 2018	BUY	$13.76 - $17.12 $302,720 - $376,640	22,000 New	22,000 $331,000

278

324M

260K

261K

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $3.06B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.